drugset / Trial / NCT02781753
Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Chinese Healthy Volunteers
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the dosages of recombinant human serum albumin/interferon alpha2b fusion protein injection in healthy subjects.
Timeline
- Start
- 2016-04-07
- Primary completion
- 2016-08-02
- Completion
- 2017-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Peginterferon alfa-2a | Protein / enzyme biologic | 180 ug | Subcutaneous |
| Subject | interferon alfa-2b | Protein / enzyme biologic | 300 ug | Subcutaneous |
| Subject | interferon alfa-2b | Protein / enzyme biologic | 1200 ug | Subcutaneous |
Indications
No indication recorded.